Nektar Therapeutics (NASDAQ:NKTR)
| 3.14 Delayed Data As of Sep 23 |  -0.085 / -2.64%Today’s Change | 3.02 Today|||52-Week Range 19.37 | -76.79% Year-to-Date |
Latest NKTR News | Press Releases
No recent news for Nektar Therapeutics.
Today’s Trading
| Previous close | 3.22 |
| Today’s open | 3.14 |
| Day’s range | 3.07 - 3.18 |
| Volume | 142,160 |
| Average volume (3 months) | 2,779,772 |
| Market cap | $588.5M |
Data as of 4:00pm ET, 09/23/2022
Growth & Valuation
| Earnings growth (last year) | -14.83% |
| Earnings growth (this year) | +24.06% |
| Earnings growth (next 5 years) | +9.25% |
| Revenue growth (last year) | -33.36% |
| P/E ratio | NM |
| Price/Sales | 24.30 |
| Price/Book | 0.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACETAdicet Bio Inc | +0.25 | +1.83% |
| MRSNMersana Therapeutics... | -0.47 | -7.16% |
| AGENAgenus Inc | -0.10 | -4.46% |
| NSTGNanoString Technolog... | -0.12 | -0.91% |
Data as of 4:00pm ET, 09/23/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $101.9M |
| Annual profit (last year) | -$523.8M |
| Net profit margin | -514.03% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
